MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-10-2026
Apyx Medical Corporation Total Non Current Liabilities 2011-2026 | APYX
Annual Total Non Current Liabilities Apyx Medical Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.1 M | 1.18 M | 140 K | 2.98 M | 3.62 M | 3.92 M | 16.4 M | 8.93 M | 3.37 M | 3.73 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.4 M | 140 K | 4.53 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 215.63 | -4.38 % | $ 15.2 B | USA |
 |
Profound Medical Corp.
PROF
|
2.44 M | $ 5.78 | 12.23 % | $ 180 M |  Canada |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Quanterix Corporation
QTRX
|
21.5 M | $ 3.92 | 2.62 % | $ 167 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 9.54 | - | $ 735 M | USA |
 |
AVITA Medical
RCEL
|
2.35 M | $ 3.97 | 3.39 % | $ 111 M |  Australia |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.33 | -1.48 % | $ 21.5 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.55 | -0.77 % | $ 7.07 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 36.9 | 0.86 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
4.04 B | $ 32.43 | 0.82 % | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.73 | 0.12 % | $ 209 M | USA |
 |
Sensus Healthcare
SRTS
|
1.66 M | $ 4.21 | 6.31 % | $ 68.7 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | Canada |
 |
Tactile Systems Technology
TCMD
|
14.1 M | $ 26.86 | -0.02 % | $ 614 M | USA |
 |
TELA Bio
TELA
|
30.2 M | $ 0.7 | -7.88 % | $ 16 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.67 | -3.33 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
42.5 K | $ 2.38 | 10.12 % | $ 3.71 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 24.02 | -2.02 % | $ 1.63 B | USA |
 |
InspireMD
NSPR
|
3.49 M | $ 1.76 | -0.56 % | $ 113 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 11.33 | -1.31 % | $ 1.53 B | USA |
 |
Penumbra
PEN
|
89.2 M | $ 336.05 | 0.54 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
275 K | $ 0.69 | -0.33 % | $ 28.9 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.28 | -5.0 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.7 | -5.37 % | $ 138 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.22 | 1.95 % | $ 381 M | USA |
 |
Outset Medical
OM
|
436 M | $ 3.49 | -1.27 % | $ 53.1 K | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 51.29 | -1.52 % | $ 1.51 B | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.29 | -1.53 % | $ 52.5 M | USA |